Testing a tobacco cessation program for American Indian communities
Testing All Nations Snuff Out Smokeless (ANSOS) for Efficacy in Multi-Tribal Urban Communities
This study is testing a special program designed to help American Indian people quit using smokeless tobacco by providing support and counseling that respects their culture.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 384 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Lehigh University Academic / other |
| Locations | 1 site (Bethlehem, Pennsylvania) |
| Trial ID | NCT06566703 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the efficacy of the All Nations Snuff Out Smokeless (ANSOS) program, a culturally tailored intervention aimed at helping American Indian individuals quit smokeless tobacco. Participants are randomly assigned to either the ANSOS intervention group, which includes group support sessions and individual counseling, or a wait-list control group receiving a Healthy Living educational intervention. The program incorporates cultural elements and addresses historical trauma and mistrust in medical research. The study aims to engage participants over a 12-month period, with follow-up measures taken at six months.
Who should consider this trial
Good fit: Ideal candidates are American Indian adults aged 18 and over who use smokeless tobacco daily and can participate in Zoom sessions.
Not a fit: Patients who do not have a stable phone number or are unable to attend Zoom sessions may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve smokeless tobacco cessation rates among American Indian communities.
How similar studies have performed: Other studies have shown success with culturally tailored tobacco cessation programs, indicating potential for positive outcomes in similar approaches.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and over * Stable telephone number that can be used for the purpose of the study * Willing to be followed for 12 months and participate in study activities * Able to attend Zoom sessions * Current SLT user, at least once per day * Self-reported AI Exclusion Criteria: * Cannot provide a stable phone number for 12 months for the purpose of the study * Unable to attend Zoom sessions
Where this trial is running
Bethlehem, Pennsylvania
- Lehigh University — Bethlehem, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Christine M Daley, PhD — Lehigh University
- Study coordinator: Christine M Daley, PhD
- Email: cmdaley@lehigh.edu
- Phone: 610-758-1878
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.